FDA Issues Final Rule on Labeling for Over-the-Counter Vaginal Contraceptives Containing Nonoxynol 9

Summary

The Food and Drug Administration (FDA) is requiring new warning statements and labeling information for over-the-counter vaginal contraceptive products containing nonoxynol 9 (N9), which will advise consumers of potential risks and side effects, including increased risk of HIV transmission from an infected partner.